Ginkgo Bioworks Holdings Management
Management criteria checks 3/4
Ginkgo Bioworks Holdings' CEO is Jason Kelly, appointed in Jan 2008, has a tenure of 16.83 years. total yearly compensation is $262.50K, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 3.84% of the company’s shares, worth MX$336.10M. The average tenure of the management team and the board of directors is 6.3 years and 2.7 years respectively.
Key information
Jason Kelly
Chief executive officer
US$262.5k
Total compensation
CEO salary percentage | 95.2% |
CEO tenure | 16.8yrs |
CEO ownership | 3.8% |
Management average tenure | 6.3yrs |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$898m |
Mar 31 2024 | n/a | n/a | -US$854m |
Dec 31 2023 | US$263k | US$250k | -US$893m |
Sep 30 2023 | n/a | n/a | -US$857m |
Jun 30 2023 | n/a | n/a | -US$1b |
Mar 31 2023 | n/a | n/a | -US$2b |
Dec 31 2022 | US$263k | US$250k | -US$2b |
Sep 30 2022 | n/a | n/a | -US$4b |
Jun 30 2022 | n/a | n/a | -US$3b |
Mar 31 2022 | n/a | n/a | -US$2b |
Dec 31 2021 | US$381m | US$250k | -US$2b |
Sep 30 2021 | n/a | n/a | -US$276m |
Jun 30 2021 | n/a | n/a | -US$200m |
Mar 31 2021 | n/a | n/a | -US$175m |
Dec 31 2020 | US$11m | US$250k | -US$127m |
Compensation vs Market: Jason's total compensation ($USD262.50K) is about average for companies of similar size in the MX market ($USD306.93K).
Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.
CEO
Jason Kelly (43 yo)
16.8yrs
Tenure
US$262,500
Compensation
Dr. Jason Kelly serves as Director of Genomatica, Inc. Dr. Kelly founded Ginkgo Bioworks, Inc. (nka:Ginkgo Bioworks Holdings, Inc.) in 2008 and serves as its Chief Executive Officer and has been Director s...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 16.8yrs | US$262.50k | 3.84% MX$ 336.1m | |
Founder | 16.8yrs | US$262.50k | 4.18% MX$ 365.9m | |
Chief Financial Officer | 4yrs | US$1.69m | 0.082% MX$ 7.2m | |
Founder | no data | no data | 0% MX$ 0 | |
Founder | no data | no data | 4.28% MX$ 375.0m | |
Founder | no data | no data | 4.17% MX$ 365.1m | |
Chief Accounting Officer | 1.5yrs | no data | 0.011% MX$ 949.9k | |
General Counsel & Secretary | no data | no data | no data | |
Senior Vice President of Corporate Development | no data | no data | no data | |
Head of People | 6.8yrs | no data | no data | |
Head of Design | 6.1yrs | no data | no data | |
Head of Omics & Analytical Chemistry | 6.3yrs | no data | no data |
6.3yrs
Average Tenure
43yo
Average Age
Experienced Management: DNA *'s management team is seasoned and experienced (6.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 16.8yrs | US$262.50k | 3.84% MX$ 336.1m | |
Founder | 16.8yrs | US$262.50k | 4.18% MX$ 365.9m | |
Member of Biopharma Advisory Board | less than a year | no data | no data | |
Member of Biopharma Advisory Board | less than a year | no data | no data | |
Independent Director | 3.2yrs | US$459.38k | 0.037% MX$ 3.2m | |
Member of Biopharma Advisory Board | less than a year | no data | no data | |
Independent Director | 8.8yrs | US$477.50k | 0.060% MX$ 5.3m | |
Independent Director | 2.3yrs | US$448.67k | 0.0075% MX$ 656.6k | |
Independent Director | 3.2yrs | US$457.50k | 0.031% MX$ 2.7m | |
Independent Chairman of the Board | 9.8yrs | US$485.19k | 0.11% MX$ 9.7m | |
Member of Biopharma Advisory Board | less than a year | no data | no data | |
Member of Biopharma Advisory Board | less than a year | no data | no data |
2.7yrs
Average Tenure
62yo
Average Age
Experienced Board: DNA *'s board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.